[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Interferon Alpha-2a Biosimilar Market Status and Outlook 2018-2025

August 2018 | 118 pages | ID: GD93CB2D559EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Roche
  • Biosidus
  • Zydus Cadila
  • Nanogen
  • Amega Biotech
  • Rhein Minapharm Biogenetics
  • PROBIOMED
  • 3sbio
Market by Type
  • Long-lasting Type
  • Ordinary Type
Market by Application
  • Hepatitis C
  • Hepatitis B
  • Other
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Interferon Alpha-2a Biosimilar Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Long-lasting Type
  3.1.2 Ordinary Type
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hepatitis C
  4.1.2 Hepatitis B
  4.1.3 Other
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Long-lasting Type Production by Region
    6.1.1.2 Ordinary Type Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hepatitis C Production by Region
    6.1.2.2 Hepatitis B Production by Region
    6.1.2.3 Other Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Long-lasting Type Demand by Region
    6.2.1.2 Ordinary Type Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hepatitis C Demand by Region
    6.2.2.2 Hepatitis B Demand by Region
    6.2.2.3 Other Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Roche
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Biosidus
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Zydus Cadila
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Nanogen
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Amega Biotech
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Rhein Minapharm Biogenetics
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 PROBIOMED
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 3sbio
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Interferon Alpha-2a Biosimilar Industry Dynamics & Regulations List
Table Global Interferon Alpha-2a Biosimilar Sales Revenue, Cost and Margin, 2015-2018E
Table Global Interferon Alpha-2a Biosimilar Market Status by Type 2015-2018E, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market Status by Application 2015-2018E, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market Status by Application 2015-2018E, in Volume
Table Global Interferon Alpha-2a Biosimilar Market by Region 2015-2018E, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market Share by Region in 2018, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market by Region 2015-2018E, in Volume
Table Global Interferon Alpha-2a Biosimilar Market Share by Region in 2018, in Volume
Table Long-lasting Type Production Value by Region 2015-2018E, in USD Million
Table Long-lasting Type Production Volume by Region 2015-2018E, in Volume
Table Ordinary Type Production Value by Region 2015-2018E, in USD Million
Table Ordinary Type Production Volume by Region 2015-2018E, in Volume
Table Hepatitis C Production Value by Region 2015-2018E, in USD Million
Table Hepatitis C Production Volume by Region 2015-2018E, in Volume
Table Hepatitis B Production Value by Region 2015-2018E, in USD Million
Table Hepatitis B Production Volume by Region 2015-2018E, in Volume
Table Other Production Value by Region 2015-2018E, in USD Million
Table Other Production Volume by Region 2015-2018E, in Volume
Table Long-lasting Type Market Size by Region 2015-2018E, in USD Million
Table Long-lasting Type Market Size by Region 2015-2018E, in Volume
Table Ordinary Type Market Size by Region 2015-2018E, in USD Million
Table Ordinary Type Market Size by Region 2015-2018E, in Volume
Table Hepatitis C Market Size by Region 2015-2018E, in USD Million
Table Hepatitis C Market Size by Region 2015-2018E, in Volume
Table Hepatitis B Market Size by Region 2015-2018E, in USD Million
Table Hepatitis B Market Size by Region 2015-2018E, in Volume
Table Other Market Size by Region 2015-2018E, in USD Million
Table Other Market Size by Region 2015-2018E, in Volume
Table GlobalInterferon Alpha-2a Biosimilar Forecast by Type 2019F-2025F, in USD Million
Table Interferon Alpha-2a Biosimilar Forecast by Type 2019F-2025F, in Volume
Table Interferon Alpha-2a Biosimilar Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Interferon Alpha-2a Biosimilar Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Interferon Alpha-2a Biosimilar Market Forecast by Region 2019F-2025F, in USD Million
Table Interferon Alpha-2a Biosimilar Market Forecast by Region 2019F-2025F, in Volume
Table Roche Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Roche
Table Biosidus Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Biosidus
Table Zydus Cadila Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Zydus Cadila
Table Nanogen Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Nanogen
Table Amega Biotech Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Amega Biotech
Table Rhein Minapharm Biogenetics Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of Rhein Minapharm Biogenetics
Table PROBIOMED Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of PROBIOMED
Table 3sbio Information
Table Interferon Alpha-2a Biosimilar Sales, Cost, Margin of 3sbio
Table Global Interferon Alpha-2a Biosimilar Sales Revenue by Company 2015-2017, in USD Million
Table Global Interferon Alpha-2a Biosimilar Sales Volume by Company 2015-2017, in Volume
Table Global Interferon Alpha-2a Biosimilar Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Interferon Alpha-2a Biosimilar Picture
Figure Interferon Alpha-2a Biosimilar Industry Chain Diagram
Figure Global Interferon Alpha-2a Biosimilar Sales Revenue 2015-2018E, in USD Million
Figure Global Interferon Alpha-2a Biosimilar Sales Volume 2015-2018E, in Volume
Figure Global Interferon Alpha-2a Biosimilar Market Status by Type 2015-2018E, in Volume
Figure North America Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure North America Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Europe Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Europe Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure South America Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure South America Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Middle East Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Africa Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Africa Interferon Alpha-2a Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Global Interferon Alpha-2a Biosimilar Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Interferon Alpha-2a Biosimilar Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Interferon Alpha-2a Biosimilar Sales Price Forecast 2019F-2025F
Figure Global Interferon Alpha-2a Biosimilar Gross Margin Forecast 2019F-2025F
Figure Global Interferon Alpha-2a Biosimilar Sales Revenue by Company in 2018, in USD Million
Figure Global Interferon Alpha-2a Biosimilar Price by Company in 2018
Figure Global Interferon Alpha-2a Biosimilar Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories